TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Long Term Provisions | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
What is the latest Long Term Provisions ratio of TRIDENT LIFELINE ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹0.07 Cr |
| Mar2024 | ₹0.07 Cr |
| Mar2023 | ₹0.07 Cr |
| Mar2022 | ₹0.07 Cr |
How is Long Term Provisions of TRIDENT LIFELINE Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.07 Cr | 0.00 | |
| Mar2024 | ₹0.07 Cr | 0.00 | |
| Mar2023 | ₹0.07 Cr | 1.45 | |
| Mar2022 | ₹0.07 Cr | - | |
Compare Long Term Provisions of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹314.2 Cr | -0.1% | -0.5% | -3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -0.1% |
-0.5% |
-3.6% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses